Alterations in AR-FOXA1 signaling in prostate cancer progression and therapeutic resistance
The androgen receptor (AR) is instrumental in the onset and progression of prostate cancer (PCa), establishing androgen deprivation therapy (ADT) as the first-line treatment for metastatic disease. However, the effectiveness of ADT is commonly short-lived. Many patients eventually relapse and develo...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2026-02-01
|
| Sarja: | Journal of the National Cancer Center |
| Aiheet: | |
| Linkit: | http://www.sciencedirect.com/science/article/pii/S2667005425000602 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|